Company intelligence / Profile preview

Hunan Siweikang Pharmaceutical

Changsha, Hunan, China

Ownership: Private
Development stage: Other

Overview

Hunan Siweikang Pharmaceutical is a biotechnology company based in Changsha, China, serving as a key manufacturing and R&D hub for Stemirna Therapeutics. The company specializes in the development and large-scale production of mRNA-based therapeutics and vaccines, utilizing proprietary lipid nanoparticle (LNP) delivery systems. Its primary focus has been the development of mRNA vaccines for COVID-19 and personalized cancer vaccines. The facility in Hunan is designed to meet GMP standards for global supply and represents a significant investment in China's mRNA industrial chain. Siweikang integrates research, pilot testing, and industrialization to accelerate the clinical translation of mRNA technology.

Therapeutic areas: OncologyInfectious Diseases
Modalities: mRNA-based drugsLipid nanoparticle delivery therapyVaccine
Industry: Biotech

Beyond the preview

Go deeper on Hunan Siweikang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hunan Siweikang Pharmaceutical.

Explore the full profile